A new study predicts cognitive decline rates in people with early Alzheimer's and explores how new drugs may slow this process. Researchers found that prediction models can estimate the rate of decline but with some uncertainty. These models could eventually help answer practical questions about quality of life for patients. The findings highlight the potential of new treatments to delay cognitive impairment.